Aldeyra Therapeutics investigational compound

· Aldeyra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aldeyra Therapeutics investigational compound, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy [Phase 3]